News from acelrx pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Oct 22, 2014, 07:00 ET
AcelRx logo.

AcelRx Announces Publication of Zalviso Phase 3 Abdominal Trial Results

 AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) today announced that results from the  IAP310 study have been published in Regional...

Oct 16, 2014, 07:00 ET
AcelRx logo.

AcelRx Pharmaceuticals Provides Update on its Patent Portfolio for Zalviso™ and its Proprietary Platform Technologies

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Oct 10, 2014, 07:00 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Pharmaceuticals Announces Multiple Sublingual Sufentanil Data Presentations At The American Society Of Anesthesiologists Meeting

 AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) today announced that multiple moderated poster presentations will be made at the upcoming American...

Oct 06, 2014, 07:00 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

Sufentanil sublingual tablet system study results to be presented at the International Association for the Study of Pain Meeting

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Sep 26, 2014, 07:00 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Pharmaceuticals Provides Regulatory Update on Zalviso™

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of...

Sep 10, 2014, 07:00 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Announces Publication of Manuscript Analyzing Cost of Intravenous Patient-Controlled Analgesia with Opioids

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Sep 04, 2014, 07:00 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Announces Publication of Sufentanil Sublingual Tablet System vs. Intravenous Patient-Controlled Analgesia with Morphine for Postoperative Pain Study Results

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Aug 27, 2014, 07:00 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Pharmaceuticals to Participate in Two Upcoming Investor Events

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Aug 11, 2014, 16:00 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Pharmaceuticals Reports Second Quarter 2014 Financial Results

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

Aug 08, 2014, 07:00 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Pharmaceuticals to Participate in Three Upcoming Investor Events

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Aug 07, 2014, 07:00 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Pharmaceuticals to Hold Second Quarter Financial Results Conference Call and Webcast on Monday, August 11th, 2014.

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Jul 25, 2014, 21:59 ET

AcelRx Pharmaceuticals Receives Complete Response Letter from FDA for New Drug Application for Zalviso™

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of...

Jul 24, 2014, 23:49 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Pharmaceuticals Confirms July 27, 2014 PDUFA Date for Zalviso

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of...

Jul 07, 2014, 03:00 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx and Grunenthal Announce Submission of European Marketing Authorization Application for ZALVISO™

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX) and Grunenthal Group announced today that Grunenthal has submitted a Marketing Authorization...

Jun 19, 2014, 07:00 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Pharmaceuticals to Present at the JMP Securities Healthcare Conference

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Jun 03, 2014, 07:00 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

Results of Cost Analysis Study Presented at ISPOR Meeting Identify Intravenous Patient-Controlled Analgesia (IV PCA) Costs of $200 to $240 for Two Days of Post-Surgical Pain Management

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Jun 02, 2014, 16:13 ET

AcelRx Pharmaceuticals Announces The Departure Of David Chung

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

May 29, 2014, 08:00 ET

AcelRx Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

AcelRx Pharmaceuticals to Present at the Jefferies Global Healthcare Conference /* Style Definitions...

May 19, 2014, 11:59 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference

AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference /* Style Definitions...

May 08, 2014, 16:05 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Pharmaceuticals Reports First Quarter 2014 Financial Results

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...